LOTTE BIOLOGICS

About

LOTTE BIOLOGICS is a contract development and manufacturing organization (CDMO) that provides end-to-end services for biopharmaceutical companies developing and producing therapeutic drugs. The company operates manufacturing facilities in Syracuse, New York, and Incheon, South Korea, and serves clients across the product life cycle from development through clinical and commercial production. Their Syracuse facility has a manufacturing capacity of 40,000 liters of Drug Substance, while their new Songdo Bio Campus in South Korea will feature 120,000 liters of capacity when operations begin in 2027.

The company is dedicated to improving patient outcomes worldwide through scientific expertise, quality manufacturing, and commitment to diversity and sustainability. LOTTE BIOLOGICS emphasizes robust quality systems and proven regulatory track records at their GMP-certified facilities to deliver high-quality products to their customers.

Services offered include:

• Development services across the product life cycle, including process verification and technology transfer
• cGMP manufacturing services for clinical and commercial drug substance supply
• Analytical testing services including analytical tech transfer, in-process testing, finished product testing, and stability testing
• Quality control testing services
• Antibody-drug conjugate (ADC) services, including conjugation of ADCs that combine monoclonal antibodies with small-molecule drugs using stable linkers

Contact Information